Abstract
Using in vivo confocal Ca 2+ imaging, we investigated whether oral application of kokumi substances elicits responses in trigeminal somatosensory ganglion neurons of the mouse. Our results show that 100 µM γEVG (γ-Glu-Val-Gly), a potent kokumi stimulus, evokes responses in a very small fraction (0.6 %) of neurons in area V3 (oral sensory field) of the trigeminal ganglion. By comparison, cooled artificial saliva elicited thermal-evoked responses in >7 % of V3 trigeminal ganglion neurons. γEVG-evoked responses were small and quite variable, with latencies ranging from 2 to over 200 sec. Co-application of the calcium sensing receptor (CaSR) inhibitor NPS-2143 significantly decreased γEVG-evoked activity. Furthermore, we show that 4 additional kokumi substances evoked responses in mouse trigeminal ganglion neurons. All neurons responding to kokumi compounds were small cells, with mean diameters below 20 µm.
In summary, our data show that certain physiological and pharmacological properties of responses to kokumi compounds can be recorded from sensory neurons in the trigeminal ganglion of living mice. Thus, sensory neurons in the somatosensory trigeminal ganglia may transmit signals from the oral cavity to the central nervous system to generate the texture perceptions that are part of the enigmatic sensations evoked by kokumi substances.
Introduction
Sensations elicited by kokumi substances are difficult to define and to quantify. It is often described as "mouthfulness", "thickness", and "continuity"-characteristics that cannot readily be explained in terms of taste alone. Kokumi compounds, though themselves evoking no taste, are also claimed to enhance sweet, salty, and umami tastes (Ohsu et al, 2010) . These features are not easily measured and often rely on human sensory panels and verbal descriptions. Finding an animal model that can be used to test and quantify kokumi sensations would be valuable for research and development of kokumi compounds. This chapter outlines progress along those lines and describes a new approach to analyzing koku taste in a mouse model. Afferent somatosensory neurons in the trigeminal ganglion innervate the tongue and oral surfaces. These neurons are sensitive to many different modalities, including mechanical, thermal, chemesthetic, and nociceptive stimuli. Trigeminal sensory neurons may thus participate in transmitting sensations such as texture and viscosity, which could be perceived as mouthfulness, thickness, and continuity. Interestingly, trigeminal sensory neurons in the rat are reported to express a calcium sensing-receptor, CaSR (Heyeraas et al, 2008) , which has been shown to be activated by kokumi substances (Oshu et al, 2010; Amino et al, 2016) . Collectively, these features provide a rationale for studying the involvement of trigeminal ganglion somatosensory neurons in responses to kokumi compounds. Accordingly, we have taken advantage of a powerful new experimental approach that combines Ca 2+ imaging, geneticallyengineered mice, and in vivo scanning laser confocal microscopy ( Fig. 1 ) to investigate responses of mouse trigeminal ganglion neurons to oral stimulation with kokumi stimuli. Our aim was to determine whether trigeminal ganglion neurons respond to kokumi substances that are 4 presented in the oral cavity, and in particular, to stimulation by the prototypic koku substance, γglutamyl-valinyl-glycine (EVG). Using this animal model, we tested sensory neuron responses to EVG in the living animal and characterized some of the properties of this kokumi compound.
Our particular interests were in the viscous sensations elicited by EVG and in the identity of possible membrane receptors for that compound.
<Fig. 1 near here> 5 3. Methodology
Animal model
We used transgenic mice that express the calcium indicator GCaMP3 or GCaMP6s in sensory neurons, including those in the trigeminal ganglion (Leijon et al, 2019) . GCaMP3 mice were obtained from X. Dong, Johns Hopkins and express GCaMP3 as a knock-in/knockout at the Pirt locus (Kim, Chu et al, 2014) . We also used floxed GCaMP6s (Jax #024106) crossed with Pirt-Cre mice (X Dong, Johns Hopkins) to generate mice in which sensory neurons expressed GCaMP6s. All mice were backcrossed to C57Bl/6 for 8-10 generations and adult mice of both sexes were used. Animals were housed with a 12-hour light cycle and food and water ad libitum and all experiments were carried out during the daylight cycle. All procedures for surgery and euthanasia were reviewed and approved by the University of Miami IACUC.
Surgical preparation
Mice were anesthetized with ketamine and xylazine (intraperitonially 120 mg/kg ketamine, 10 mg/kg xylazine) and anesthetic depth was monitored by the hind paw withdrawal reflex.
Ketamine booster injections were administered to ensure continued surgical plane of anesthesia throughout the surgery and imaging session. The animal's core temperature was continuously monitored with a rectal probe and maintained between 35 and 36 o C.
For the initial stage of surgery, the anesthetized mouse was placed supine on a far infrared surgical warming pad (DCT-15, Kent Scientific). The trachea was exposed and cannulated for 6 facilitated respiration during oral stimulus presentation. A flexible tube was inserted through the esophagus to produce a uniform stimulus delivery into the oral cavity (Sollars and Hill 2005; Wu, Dvoryanchikov et al. 2015; Leijon et al, 2019) . Next, the mouse was placed in prone position for surgical exposure of the region of the trigeminal ganglion that innervates the oral cavity, V3 (Fig. 2) . Muscle tissue on the dorsolateral side of the skull was cauterized and the zygomatic arch removed. A small cranial window was drilled open and hemispherectomy was performed by careful aspiration to allow optical access to the dorsal part of the trigeminal ganglion. The head was stabilized by affixing a custom head holder to the skull with a nylon screw and dental acrylic. To maintain a favorable neuronal environment, from the moment of exposure the ganglion was intermittently rinsed with Tyrode's solution at 35 o C.
<Fig. 2 near here>

Functional in vivo confocal calcium imaging
The surgically-prepared mouse was transferred to the stage of an Olympus FV1000 confocal microscope equipped with a 10x-long working distance objective, (UPlanFl, N.A. 0.3). Confocal scans of GCaMP3-/GCAMP6s-labeled ganglion neurons were taken at ∼1 hz using 488-nm laser excitation with a 505-605 nm emitter filter. Stimuli were applied as 1 mL over 10 seconds, delivered retrogradely via the esophageal tube. When temperature stimuli were applied, the resulting oral temperature was measured with a thermal probe connected to a wireless transmitter (UWBT-TC-UST-NA, OMEGA Engineering, Inc.).
Reagents 7
All reagents were purchased from Sigma apart from kokumi substances, which were obtained from Ajinomoto Co. Inc. These included glutathione (GSH; CAS 70-18-8), γ-glutamyl-alphaaminobutyrate (γ-Glu-Abu; CAS 16869-42-4), γ-glutamyl-valinyl-glycine (γ EVG, γ-Glu-Val-Gly; CAS 38837-70-6), poly-L-lysine (CAS 28211-04-3), cinacalcet-HCl (CAS 364782-34-3), and the Calcium-Sensing Receptor inhibitor NPS-2143. Stock solutions of kokumi substances were dissolved in H20 and stored at 4° C. On the experimental day, kokumi stimuli were diluted to working solutions in artificial saliva containing 15 mM NaCl, 22 mM KCl, 3 mM CaCl2, 0.6 mM MgCl2, pH 5.8.
Data analysis
Optical scans of neuronal fluorescence were digitized using Fluoview software (Olympus) and videoimages were stabilized using FIJI (ImageJ). Baseline-subtracted videos were used to identify areas with potential neuronal responses and regions of interest (ROIs) were manually drawn over individual ganglion neurons. ROIs were analyzed with MatLab (Mathworks) using custom code, modified from Wu et al., 2015, to correct for any small baseline drifts. Calcium transients were quantified as peak stimulus-evoked fluorescence change (ΔF) divided by baseline fluorescence (F0), i.e. ΔF/F0. The criterion for identifying responses was ΔF/F0 > 5 standard deviations above baseline (Fig 3) . For thermal stimuli, criteria also included that responses occurred at consistent latencies after stimulus onset. A single field of view, within the V3 area of the trigeminal ganglion, was analyzed for each experimental animal. At the end of an experiment, the animal was euthanized by CO2 followed by cervical dislocation.
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Unless otherwise specified, statistical significance was determined using two-tailed Student's ttest between two groups, otherwise by unpaired or paired one-way ANOVA, using Prism v.6 (GraphPad). Statistical significance was defined as p<0.05. (Maruyama et al, 2012) , and in human sensory analyses (Kuroda & Miyamura, 2015) . Thus, we investigated whether the CaSR inhibitor NPS-2143 had an effect on EVGevoked responses recorded in vivo from trigeminal ganglion neurons. We recorded responses to oral stimulation with EVG alone or in combination with 30 µM NPS 2143 ( Fig. 8 ). Because EVG often elicited multiple calcium transients ( Fig. 5) , we calculated the area under curve (AUC) to quantify EVG responses. The results showed that NPS significantly decreased EVG responses (p<0.0001) ( Fig. 8) . NPS had no effect on stimulation with artificial saliva (p>0.05, Fig. 8a ). To exclude the possibility that the decline in EVG responses following NPS treatment was merely due to "rundown" during prolonged recordings, we conducted a second series of experiments where EVG alone was applied twice in the absence of the CaSR inhibitor ( Fig. 8b) .
Importantly, there was no decrease in AUC of EVG responses (p=0.29). Furthermore, there was no difference between AUC measurements from EVG alone responses between the first and second of these series of experiments (p=0.5589). These data suggest that EVG-evoked responses in the trigeminal ganglion neurons can be inhibited by applying the CaSR inhibitor NPS 2143 into the oral cavity. In human sensory analyses, kokumi substances stimulate a sensation of enhanced thickness and mouthfeel during food intake (Oshu et al, 2010) . We investigated whether a viscous solution evoked neuronal responses and whether viscosity affected EVG responses. Xanthan gum is a common commercial food thickener. Xanthan gum alone (0.5%) appeared to evoke responses in trigeminal ganglion neurons but the effects were diffuse and difficult to quantify (Fig 9) . To 12 analyze the data we removed data (F/F 0 ) that was did not reach a level of 5 times the standard deviation above baseline and calculated the area under the remaining signal (AUC). We also counted the number of peaks in F/F 0 (Fig 9c) . The results show that oral xanthan gum alone evoked increased activity in trigeminal ganglion neurons. Stimulating with a combination of EVG and xanthan gum resulted in a somewhat larger AUC for the combination response than that evoked by EVG alone, but the difference was not statistically significant (p=0.51). The same result was obtained for the number of peaks (F/F 0 ) (p=0.56). Thus, oral application of the food thickener xanthan gum can evoke responses in the trigeminal ganglion, but an interaction between xanthan gum and the kokumi substance EVG cannot be confirmed. Similar to Xanthan gum, oral stimulation with glucomannan alone (0.3%) evoked responses in trigeminal ganglion neurons (Fig 10a) . There was no interaction between EVG and glucomannan. Stimulating the oral cavity with a combination of EVG and glucomannan did not evoke responses that differed from stimulating with EVG alone (no difference in AUC of the responses, p=0.37, or in number of peaks, p=0.65) (Fig 10b) . In the thickener experiments, some neurons showed responses to both EVG and thickener (xanthan gum/glucomannan). The average diameter of EVG-responding neurons was 18.2±0.7 µm (Fig. 11 ), which is not signficantly different from our previous measurements ( Fig. 7 p=0.13). The average sizes of neurons responding to xanthan gum (17.2±1.6 µm) or glucomannan (16.1±0.5 µm) were similar. . <Fig. 11 near here> 4.3 Additional kokumi substances Although EVG has been described as a potent kokumi substance (Kuroda and Miyamura, 2015) , there are other peptides with kokumi-like activity (Amino et al, 2016) (Kuroda and Miyamura, 2015) . We investigated if kokumi substances other than EVG elicited Ca 2+ responses in mouse trigeminal ganglion neurons. Specifically, we tested glutathione (GSH/-Glu-Cys-Gly; 4 mice), -Glu-Abu (2 mice), poly-L-lysine (2 mice), CaCl2 (2 mice), and the calcium-mimetic drug Cinacalcet (3 mice).
Glutathione (GSH):
The effect of GSH on taste has been known since the early 1990's when it was first extracted from garlic water and shown to enhance umami intensity (Ueda et al, 1990) .
This "intensifying" effect was termed koku. GSH has since been shown to also affect other taste qualities (e.g., Oshu et al, 2010) . We found that oral application of 1 mM GSH evoked responses in mouse trigeminal ganglion neurons. The responses (Fig 12a) were of similar latency and duration as those of EVG (Fig 6) . Across 4 mice, GSH evoked responses in 26 trigeminal ganglion neurons.
<Figs. 12 near here>
Cinacalcet: Cinacalcet acts as a calcimimetic and causes allosteric activation of CaSR. In human sensory analyses, oral 38 µM cinacalcet showed significant kokumi-like taste enhancement (Oshu et al., 2010) . We found that 100 µM cinacalcet evoked responses in the trigeminal ganglion (Fig 12b) . Across 3 mice, cinacalcet evoked responses in 12 trigeminal ganglion neurons.
CaCl2: A certain basal level of calcium is needed for kokumi substances to activate CaSR (Wang et al., 2006; Oshu et al., 2010) , and calcium salts have kokumi-like activity (Oshu et al., 2010) .
We superfused the oral cavity with 100 mM CaCl2 and observed trigeminal neuron responses that were similar in delay and characteristics to those of EVG (Fig 12c) . Across 2 mice, CaCl2 evoked responses in 11 neurons.
-Glu-Abu: The kokumi substance, -glutamyl-α-aminobutyrate (-Glu-Abu) is a natural substrate of glutathione synthetase, also known under its systematic name butanoic acid. It one of the most potent dipeptide kokumi substances (Amino et al., 2016) . (Fig 4.9d) . Across 2 mice, -Glu-Abu (800 µM) evoked responses in 11 neurons (Fig 12d) . human sensory analyses, 0.08 % polylysine has been shown sufficient to enhance taste (Oshu et al, 2010) . We found that, in the mouse, oral stimulation with polylysine (0.2 %) elicited responses only in a few trigeminal neurons. Polylysine responses were quite prolonged ( Fig   12e) . Across 2 mice, a total of 6 neurons were responsive to polylysine at this concentration.
Overlap between kokumi substances
To determine if the above kokumi substances elicited responses in identical, overlapping, or separate groups of trigeminal ganglion neurons, we applied each compound alone and sequentially in one experiment. The results indicated that 9 of the 14 neurons responded to one compound only; 5 neurons responded to 2 compounds (Fig 12f) . There was no obvious pattern in the overlap. No consistent population of "kokumi sensing" trigeminal ganglion neurons was evident.
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Discussion
In this study, we investigated responses of mouse trigeminal ganglion neurons to oral stimulation with kokumi compounds. We used transgenic mice that express GCaMP in sensory neurons to conduct in vivo imaging and analyze a number of kokumi compounds as well as testing the effect of blocking CaSR, a putative receptor for kokumi compounds.
Trigeminal sensory neuron responses to γEVG (γ-Glu-Val-Gly) had variable latencies (2 to >200 seconds) and were often characterized by prolonged activity. This likely reflects the gradual penetration of the compound into the lingual epithelium where the trigeminal afferent sensory nerve endings are situated. These trigeminal terminals can be quite superficial in the lingual epithelium (Leijon et al, 2016) . During sensory evaluations, panelists report that γEVG added to food enhances taste intensity, peaking at 10 seconds but still present up to 40 seconds (Oshu et al., 2010) . Those data would be consistent with the present study where oral stimulation with γEVG evoked long-lasting responses in trigeminal ganglion neurons.
CaSR has previously been implicated as a mechanism of action for kokumi taste both in vitro (Amino et al, 2016) and in human sensory analyses (Oshu et al, 2010 ). Thus, we tested if the CaSR inhibitor NPS-2143 affected γEVG responses. Indeed, co-application of NPS-2143 significantly decreased γEVG-evoked activity. Whether NPS-2143 selectively and specifically depresses only γEVG responses and not other stimulus-evoked activity (e.g. mechanical, thermal, or nociceptive) remains to be tested. Also, we did not test NPS-2143 on responses to other kokumi compounds such as glutathione. Moreover, it is unclear to what extent CaSR is expressed in the trigeminal ganglion. RNAseq analyses revealed CaSR expression only in few (<1%) of mouse trigeminal ganglion neurons, and only at negligible levels (Nguyen et al, 2017 ).
Yet if CaSR is only expressed in neurons that innervate the oral mucosa, this might explain the low percentage trigeminal ganglion neurons that express this receptor. It would not, however, explain the low level of CaSR expression per cell that Nguyen et al (2017) report. Taken collectively, our findings do not offer conclusive evidence for the involvement of CaSR in trigeminal neurons responses to kokumi substances.
Based on the koku characteristics "mouthfullness" or "thick flavor", we studied whether there is a sensory interaction between kokumi compounds and food thickeners. The data did not reveal significant interactions between oral EVG and xanthan gum or glucomannan. Because a population of trigeminal sensory ganglion neurons responded to oral stimulation with EVG or to xanthan gum (or glucomannan) alone, the perception of koku-enhanced thickness that sensory panels report (Oshu et al, 2010 ) may be generated by kokumi compounds stimulating viscositysensitive trigeminal sensory afferent fibers.
The list of compounds identified as kokumi substances is growing (e.g. Amino et al, 2016) . We tested 5 of these, including γEVG , glutathione (GSH), cinacalcet, -Glu-Abu, and CaCl2. All these compounds, applied orally, evoked responses in some trigeminal ganglion neurons. The response properties were mostly small (low amplitude), with variable latencies and prolonged durations. However, when tested sequentially (admittedly in a limited sample of neurons), the above 5 compounds did not stimulate a singular coherent population of trigeminal ganglion 18 neurons. This suggests that if koku sensations are indeed transmitted via somatosensory afferent of the trigeminal ganglion, there is not a uniform group of "koku-responding" neurons in that ganglion. Moreover, the relatively small population of trigeminal ganglion neurons dedicated to oral stimulation with kokumi substances (for instance compared with thermal-orosensitive neurons, Leijon et al 2019) suggest that it will remain a challenge to study koku-evoked somatosensations at the cellular level in the trigeminal ganglion. In particular, relating kokuresponsive neurons to molecular markers and eventually identifying a molecular receptor in trigeminal neurons will be challenging.
It is worth noting that kokumi substances also have been shown to activate CaSR-expressing taste bud cells (Maruyama et al, 2012) . These cells are innervated by afferent fibers from the geniculate ganglion. Indeed, taste buds in the tongue and palate are associated with fibers from both geniculate and trigeminal ganglia (Fig. 13) . Neurons from the geniculate ganglion innervate taste bud cells that are stimulated by taste substances entering through an apical taste pore. Thus, geniculate ganglion neurons typically are thought to transmit basic taste qualities such as sweet, umami, etc.. In contrast, axons from trigeminal ganglia penetrate the oral epithelium immediately surrounding taste buds, forming a halo of nerves around most taste buds. Importantly, trigeminal fibers frequently are located in very superficial layers of the epithelium, where they may be reached by oral stimuli such as γEVG. In summary, trigeminal and geniculate ganglion neurons are positioned to respond to oral stimulation with kokumi substances -trigeminal neurons by direct stimulation, and geniculate neurons following stimulation of taste bud cells. The sensory characteristics of kokumi compounds are diverse, and it is thus possible that the trigeminal and geniculate ganglia play different, or complimentary, roles in the multifaceted taste that is koku. the stimuli onsets of artificial saliva (blue) and the respective kokumi substance (orange). Note that the control stimulus (artificial saliva) did not elicit responses. f) One experiment was conducted where all 6 kokumi substances were applied sequentially. A total of 14 neurons (out of >1000)
responded to at least one kokumi substance, and 5 of those 14 neurons responded to more than one kokumi substance. Calibs, 30 sec, 1 F/F0. to label neurons and GFP (green) to mark those neurons that express TrpM8. A subset of the neurons expresses GFP/TrpM8. GFP is also present in axons from these neurons (arrowhead).
The geniculate ganglia from the same mouse, processed in parallel, did not contain GFP/TrpM8
(not shown). b) confocal micrograph of a fungiform papilla (solid outline) with a taste bud (dashed outline) in the tongue of the same Trpm8-GFP mouse. GFP/TrpM8-expressing axons surround, but do not enter the taste bud. In contrast, afferent fibers from the geniculate (gustatory) ganglion are immunoreactive for P2X2 (magenta) branch and branch extensively throughout the taste bud.
The taste pore (*), through which taste stimuli interact with taste bud cells, is indicated (*). Scale bars, 20μm. a b
